Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Batisse

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
European Journal of Nuclear Medicine and Molecular Imaging|December 6, 2023
Performance of [<sup>18</sup>F]fluorocholine PET/CT in MEN1-related primary hyperparathyroidism before initial surgery or for persistent/recurrent diseaseAymeric Boucher, Julia Delabie, Charlotte Lussey-Lepoutre, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2021
Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their DiseaseClément Mennetrey, Maëlle Le Bras, Aurélie Bando-Delaunay, et al.
Thyroid : Official Journal of the American Thyroid Association|October 19, 2023
Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF NetworkArnaud Jannin, Fabiola Giudici, Christelle de la Fouchardière, et al.
European Journal of Endocrinology|April 23, 2017
Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomasHélène Lasolle, Christine Cortet, Fréderic Castinetti, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2021
Recurrence-Free Survival Analysis in Locally Advanced Pheochromocytoma: First AppraisalSophie Moog, Frédéric Castinetti, Christine DoCao, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
European Journal of Nuclear Medicine and Molecular Imaging|December 6, 2023
Performance of [<sup>18</sup>F]fluorocholine PET/CT in MEN1-related primary hyperparathyroidism before initial surgery or for persistent/recurrent diseaseAymeric Boucher, Julia Delabie, Charlotte Lussey-Lepoutre, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2021
Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their DiseaseClément Mennetrey, Maëlle Le Bras, Aurélie Bando-Delaunay, et al.
Thyroid : Official Journal of the American Thyroid Association|October 19, 2023
Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF NetworkArnaud Jannin, Fabiola Giudici, Christelle de la Fouchardière, et al.
European Journal of Endocrinology|April 23, 2017
Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomasHélène Lasolle, Christine Cortet, Fréderic Castinetti, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2021
Recurrence-Free Survival Analysis in Locally Advanced Pheochromocytoma: First AppraisalSophie Moog, Frédéric Castinetti, Christine DoCao, et al.
Pageof 4